Page last updated: 2024-09-03

gefitinib and Neuroendocrine Tumors

gefitinib has been researched along with Neuroendocrine Tumors in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujimoto, N; Fujiwara, K; Hamazaki, S; Kiura, K; Kozuki, T; Mizobuchi, K; Shiomi, K; Tabata, M; Tanimoto, M; Ueoka, H	1
Ames, MM; Gilbert, JA; Lloyd, RV	1

Other Studies

2 other study(ies) available for gefitinib and Neuroendocrine Tumors

Article	Year
Complexity in the treatment of pulmonary large cell neuroendocrine carcinoma. Journal of cancer research and clinical oncology, 2005, Volume: 131, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Large Cell; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroendocrine Tumors; Quinazolines; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Failure; Treatment Outcome	2005
Lack of mutations in EGFR in gastroenteropancreatic neuroendocrine tumors. The New England journal of medicine, 2005, Jul-14, Volume: 353, Issue:2 Topics: Antineoplastic Agents; DNA Mutational Analysis; Drug Resistance, Neoplasm; ErbB Receptors; Gastrointestinal Neoplasms; Gefitinib; Humans; Molecular Sequence Data; Mutation; Neuroendocrine Tumors; Pancreatic Neoplasms; Polymorphism, Genetic; Protein Kinase Inhibitors; Quinazolines	2005

Article

Year

Complexity in the treatment of pulmonary large cell neuroendocrine carcinoma.

Journal of cancer research and clinical oncology, 2005, Volume: 131, Issue:3

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Large Cell; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroendocrine Tumors; Quinazolines; Radiotherapy, Adjuvant; Retrospective Studies; Treatment Failure; Treatment Outcome

2005

Lack of mutations in EGFR in gastroenteropancreatic neuroendocrine tumors.

The New England journal of medicine, 2005, Jul-14, Volume: 353, Issue:2

Topics: Antineoplastic Agents; DNA Mutational Analysis; Drug Resistance, Neoplasm; ErbB Receptors; Gastrointestinal Neoplasms; Gefitinib; Humans; Molecular Sequence Data; Mutation; Neuroendocrine Tumors; Pancreatic Neoplasms; Polymorphism, Genetic; Protein Kinase Inhibitors; Quinazolines

2005